Carryn Anderson, MD was invited to speak at the ASTRO Annual Meeting held in San Antonio, TX, where she shared the results of the Phase 3 Trial of Avasopasem Manganese (GC4419) to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer. The next development will seek to obtain FDA approval for this treatment.